Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05203185 · ClinicalTrials.gov registry record · NA
Nudging Provider Adoption of Clinical Decision Support
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 1,612
- Enrollment target
NCT05203185: Completed NA study, sponsored by NYU Langone Health.
NCT05203185 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 1,612 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05203185, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,612 participants
- Enrollment target
Study Summary
The central hypothesis of this proposal is that the addition of a theory-informed "nudge" to a clinical decision support (CDS) tool will address identified behavioral barriers to use and significantly improve adoption by providers. Nudges are applications of behavioral science, defined as positive reinforcement and indirect suggestions that have a non-forced effect on decision making. This study will use a behavioral theory-informed process to develop a new CDS tool that includes a nudge that addresses barriers to adoption.
Primary Outcome
The tool is considered adopted during a patient visit if the provider accepted the recommendation given by the PERK tool (i.e., a D-dimer was recommended and ordered or a CT pulmonary angiogram (CTPA) was recommended and ordered). This outcome measure is assessed using electronic health record (EHR) data from the patient visit.
Interventions
- OTHER Pulmonary Embolism Risk Kalculator (PERK)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,612 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2022-04-30 |
| Phase | NA |
What the finished NCT05203185 record still lists
NCT05203185 is an interventional study that assigns participants to a tested intervention. Its 1,612 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% higher).
The record links to 0 conditions, and to 1 intervention - of which Pulmonary Embolism Risk Kalculator (PERK) is the first listed.
NCT05203185 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05203185 about?
NCT05203185 is a clinical study titled "Nudging Provider Adoption of Clinical Decision Support". The central hypothesis of this proposal is that the addition of a theory-informed "nudge" to a clinical decision support (CDS) tool will address identified behavioral barriers to use and significantly improve adoption by providers. Nudges are applications of behavioral science, defined as positive r...
What is the current status of trial NCT05203185?
This trial is currently completed. It is a NA study. The enrollment target is 1,612 participants. The study started on 2021-07-01. Estimated completion is 2022-04-30.
What interventions are being tested in trial NCT05203185?
The interventions under investigation include: Pulmonary Embolism Risk Kalculator (PERK) (OTHER).
Who is sponsoring clinical trial NCT05203185?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05203185's enrollment target sits among peer trials
1,612 63rd of 2000 higher than 1,938 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06959524 · 1,616 participants · NA
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
- NCT06271590 · 1,605 participants · NA
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI